Multi-target siRNA based on DNMT3A/B homologous conserved region influences cell cycle and apoptosis of human prostate cancer cell line TSU-PR1

Genetics and Molecular Biology

Volumn 35, Issue 1, 2012, Pages 164-171

  Du, Yue feng ^a   Liang, Liang ^a   Shi, Ying ^b   Long, Qing zhi ^a   Zeng, Jin ^a   Wang, Xin yang ^a   He, Da lin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

DNA methylation; DNMT3; Prostate cancer; RNA interference

Indexed keywords

DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN TSU PR1; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN FAMILY; PROTEIN TARGETING; SEQUENCE HOMOLOGY;

EID: 84863246944     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572012005000021     Document Type: Article

References (27)

1. Auerkari EI (2006) Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis. Oral Oncol 42:5-13.
2. Bai S, Ghoshal K, Datta J, Majumder S, Yoon SO and Jacob ST (2005) DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol Cell Biol 25:751-766.
3. Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM and Waalkes MP (2007) Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect 115:1454-1459.
4. Cheng X and Blumenthal RM (2008) Mammalian DNA methyltransferases: Astructural perspective. Structure 16:341-350.
5. Das PM and Singal R (2004) DNA methylation and cancer. J Clin Oncol 22:4632-4642.
6. Ding WJ, Fang JY, Chen XY and Peng YS (2008) The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci 53:2083-2089.
7. Girault I, Tozlu S, Lidereau R and Bieche I (2003) Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9:4415-4422.
8. Hannon GJ (2002) RNA interference. Nature 418:244-251.
9. Kanai Y and Hirohashi S (2007) Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28:2434-2442.
10. Kim MS, Lee J and Sidransky D (2010) DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29:181-206.
11. Kunze D, Wuttig D, Fuessel S, Kraemer K, Kotzsch M, Meye A, Grimm MO, Hakenberg OW and Wirth MP (2008) Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells. Anticancer Res 28:2259-2263.
12. Leu YW, Rahmatpanah F, Shi H, Wei SH, Liu JC, Yan PS and Huang TH (2003) Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res 63:6110-6115.
13. Lin J, Haffner MC, Zhang Y, Lee BH, Brennen WN, Britton J, Kachhap SK, Shim JS, Liu JO, Nelson WG, et al. (2011) Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. Prostate 71:333-343.
14. Momparler RL (2003) Cancer epigenetics. Oncogene 22:6479-6483.
15. Momparler RL (2005) Pharmacology of 5-Aza-2'-deoxycytidine (decitabine). Semin Hematol 42:S9-16.
16. Morey Kinney SR, Smiraglia DJ, James SR, Moser MT, Foster BA and Karpf AR (2008) Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Res 6:1365-1374.
17. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF and Wu TC (2006) Prospects of RNA interference therapy for cancer. Gene Ther 13:464-477.
18. Patra SK, Patra A, Rizzi F, Ghosh TC and Bettuzzi S (2008) Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. Cancer Metastasis Rev 27:315-334.
19. Przybylski M, Kozlowska A, Pietkiewicz PP, Lutkowska A, Lianeri M and Jagodzinski PP (2010) Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B. Biomed Pharmacother 64:254-258.
20. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS and Khvorova A (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22:326-330.
21. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A and Macleod AR (2003) DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33:61-65.
22. Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schonfeld P, Roessner A and Gali-Muhtasib H (2005) 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther 312:525-536.
23. Sharma S, Kelly TK and Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31:27-36.
24. Siedlecki P and Zielenkiewicz P (2006) Mammalian DNA methyltransferases. Acta Biochim Pol 53:245-256.
25. Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M and Yoshikawa T (2010) Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Cancer Genet Cytogenet 197:16-24.
26. Wang JC, Wang JX, Liu HR and Zhang YG (2009) Influence of DNA methyltransferase 3b on the expression of cyclin D1 gene and methylation of its promoters in human hepatocellular carcinoma cells. Zhonghua Yi Xue Za Zhi 89:555-558 (Abstract in English).
27. Yu N and Wang M (2008) Anticancer drug discovery targeting DNA hypermethylation. Curr Med Chem 15:1350-1375.